- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 12, 2026 | 843.18K sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 838.74K sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 838.15K sh |
| Capex | Q1 2026 · Dec 31, 2025 | $316.25K |
| Capex | Q1 2026 · Dec 31, 2024 | $0 |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$239.36K |
| Operating Cash Flow | Q1 2026 · Sep 30, 2025 | $744.98K |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | $134.69K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $251.9K |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $349.83K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $86.35K |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | −$111.64K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.88M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $2.13M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $711.25K |
| Current Assets | Q1 2026 · Sep 30, 2025 | $1.24M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.14M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $2.48M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$0.12 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | $0.24 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | $0.24 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $70.27K |
| Sga Expense | Q1 2026 · Dec 31, 2024 | $51.4K |
| Net Income | Q1 2026 · Dec 31, 2025 | −$99.74K |
| Net Income | Q1 2026 · Sep 30, 2025 | $461.19K |
| Net Income | Q1 2026 · Dec 31, 2024 | $197.98K |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$115.34K |
| Operating Income | Q1 2026 · Dec 31, 2024 | $187.32K |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $286.77K |
| Gross Profit | Q1 2026 · Dec 31, 2024 | $549.42K |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $399.73K |
| Cost Of Revenue | Q1 2026 · Dec 31, 2024 | $987.21K |